Georg A. Bjarnason

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

Robert J. Motzer, Thomas E. Hutson, Piotr Tomczak et al. · Journal of Clinical Oncology · 2009 · 2.2K citations

Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis

John M.L. Ebos, Christina R. Lee, William Cruz‐Muñoz et al. · Cancer Cell · 2009 · 1.7K citations · Full text

Angiogenesis, Potent Inhibitor, Medicine +10

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma

Toni K. Choueiri, Bernard Escudier, Thomas Powles et al. · New England Journal of Medicine · 2015 · 1.2K citations · Full text

External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study

Daniel Y.C. Heng, Wanling Xie, Meredith M. Regan et al. · The Lancet Oncology · 2013 · 1K citations · Full text

External Validation, Urology, Population-based Study +9

Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial

Martin Gore, Cezary Szczylik, Camillo Porta et al. · The Lancet Oncology · 2009 · 590 citations

Urology, Oncology, Metastatic Renal-cell Carcinoma +8